HZNP Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Notice: This stock is marked as potentially delisted. It may not be actively trading.

Insider Ownership Percentage: 2.20%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

Horizon Therapeutics Public Insider Trading History Chart

Horizon Therapeutics Public Share Price & Price History

^$116.30

+0.30 (1.20%)

As of 10/6/2023 01:00 AM ET

Forced out of retirement by these trades

From DTI | Ad

You know, I never really intended to get in front of a camera and tell folks about a new market paradigm that I discovered. Even though I have a bright and shiny “resume,” I thought I’d left investing behind forever. And I was more than happy to be a stay-at-home dad… But then I discovered Gamma Pockets… and everything changed

Make sure to check out Gamma Pockets HERE while it’s still widely available

Horizon Therapeutics Public Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/17/2023	Andy Pasternak	EVP	Sell	27,129	$113.03	$3,066,390.87	56,338
1/13/2023	Aaron Cox	CFO	Sell	36,148	$113.17	$4,090,869.16	277
1/10/2023	Jeffrey W. Sherman	EVP	Sell	3,368	$113.05	$380,752.40	39,539
1/6/2023	Jeffrey W. Sherman	EVP	Sell	5,187	$113.29	$587,635.23	49,314
12/12/2022	Jeffrey W. Sherman	EVP	Sell	28,352	$111.45	$3,159,830.40	54,501
8/4/2022	Sean M Clayton	EVP	Buy	745	$66.67	$49,669.15	745
7/29/2022	Andy Pasternak	EVP	Sell	4,850	$82.57	$400,464.50	34,047
7/19/2022	Elizabeth H. Z. Thompson	EVP	Sell	90	$85.04	$7,653.60	12,886
7/7/2022	Elizabeth H. Z. Thompson	EVP	Sell	82	$85.01	$6,970.82	12,976
6/10/2022	Andy Pasternak	EVP	Sell	762	$85.36	$65,044.32	38,897
6/3/2022	Timothy P. Walbert	CEO	Sell	25,000	$92.34	$2,308,500.00	435,826
5/31/2022	Timothy P. Walbert	CEO	Sell	25,000	$92.48	$2,312,000.00	435,549
5/20/2022	Timothy P. Walbert	CEO	Sell	25,000	$90.00	$2,250,000.00	460,549
5/11/2022	Timothy P. Walbert	CEO	Sell	17,600	$90.00	$1,584,000.00	460,549
5/6/2022	Timothy P. Walbert	CEO	Sell	7,400	$90.86	$672,364.00	460,549
4/22/2022	Timothy P. Walbert	CEO	Sell	25,000	$106.59	$2,664,750.00	485,549
4/20/2022	Paul W Hoelscher	CFO	Sell	50,000	$114.71	$5,735,500.00	1,049
4/12/2022	Michael A Desjardin	EVP	Sell	20,214	$113.12	$2,286,607.68	82,346
4/8/2022	Timothy P. Walbert	CEO	Sell	25,000	$112.38	$2,809,500.00	485,549
4/6/2022	Jeffrey W. Sherman	EVP	Sell	42,009	$110.02	$4,621,830.18	10,629
4/6/2022	Paul W Hoelscher	CFO	Sell	215,335	$110.01	$23,689,003.35	1,049
3/30/2022	Timothy P. Walbert	CEO	Sell	50,000	$105.26	$5,263,000.00
3/25/2022	Paul W Hoelscher	CFO	Sell	663	$110.00	$72,930.00
3/25/2022	Timothy P. Walbert	CEO	Sell	25,000	$109.37	$2,734,250.00
3/23/2022	Paul W Hoelscher	CFO	Sell	26,090	$110.00	$2,869,900.00
3/11/2022	Timothy P. Walbert	CEO	Sell	25,000	$100.93	$2,523,250.00
2/18/2022	Andy Pasternak	EVP	Sell	1,313	$94.82	$124,498.66
2/11/2022	Timothy P. Walbert	CEO	Sell	25,000	$97.41	$2,435,250.00
1/31/2022	Timothy P. Walbert	CEO	Sell	100,000	$91.85	$9,185,000.00
1/28/2022	Timothy P. Walbert	CEO	Sell	25,000	$90.00	$2,250,000.00
1/14/2022	Timothy P. Walbert	CEO	Sell	25,000	$90.02	$2,250,500.00
1/6/2022	Andy Pasternak	EVP	Sell	7,987	$99.57	$795,265.59
12/28/2021	Paul W Hoelscher	CFO	Sell	8,575	$110.00	$943,250.00

Mysterious drone activity triggers massive 1,366% surge

From Insiders Exposed | Ad

If mysterious drones buzzing over the East Coast weren’t on your radar this year, you’re not alone. But here’s what you really need to know: An early warning signal tipped off investors to a tiny drone stock that later skyrocketed 1,366%.

👉 Click here now to see how this signal works.

SEC Filings (Institutional Ownership Changes) for Horizon Therapeutics Public (NASDAQ:HZNP)

80.37% of Horizon Therapeutics Public stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Horizon Therapeutics Public Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
12/19/2023	Public Employees Retirement System of Ohio	140,586	$16.26M	0.1%	+29.8%	0.061%
12/18/2023	Vanguard Group Inc.	21,587,441	$2.50B	0.1%	+0.2%	9.427%
12/7/2023	Hudson Bay Capital Management LP	1,907,386	$220.67M	1.7%	+57.3%	0.833%
11/29/2023	Carmignac Gestion	68,347	$7.91M	0.1%	+83.1%	0.030%
11/24/2023	Deutsche Bank AG	728,802	$84.32M	0.1%	-68.0%	0.318%
11/22/2023	Public Sector Pension Investment Board	128,000	$14.81M	0.1%	-16.3%	0.056%
11/16/2023	Orion Capital Management LLC	5,450	$0.63M	0.4%	-24.8%	0.002%
11/16/2023	Tudor Investment Corp Et Al	1,303,844	$150.84M	1.5%	+2.9%	0.569%
11/16/2023	Public Employees Retirement System of Ohio	140,586	$16.26M	0.1%	+29.8%	0.061%
11/16/2023	Morgan Stanley	2,839,854	$328.54M	0.0%	-5.4%	1.240%
11/15/2023	Stonebridge Capital Advisors LLC	450	$52K	0.0%	+800.0%	0.000%
11/15/2023	Toroso Investments LLC	6,686	$0.77M	0.0%	+30.2%	0.003%
11/15/2023	TAM Capital Management Inc.	94,873	$10.98M	7.2%	N/A	0.041%
11/15/2023	Royal London Asset Management Ltd.	83,038	$9.61M	0.0%	+3.4%	0.036%
11/15/2023	Rock Springs Capital Management LP	255,500	$29.56M	0.8%	-48.4%	0.112%
11/15/2023	Sectoral Asset Management Inc.	2,515	$0.29M	0.1%	-68.2%	0.001%
11/15/2023	Knightsbridge Asset Management LLC	54,945	$6.36M	2.0%	-0.4%	0.024%
11/15/2023	KRYGER CAPITAL Ltd	1,222,616	$141.44M	16.3%	+22.7%	0.534%
11/15/2023	Laurion Capital Management LP	1,453,206	$168.12M	1.0%	-7.4%	0.635%
11/15/2023	Adage Capital Partners GP L.L.C.	2,936,633	$339.74M	0.8%	-1.9%	1.282%
11/15/2023	Advisors Asset Management Inc.	3,367	$0.39M	0.0%	-15.2%	0.001%
11/15/2023	First National Bank of Omaha	38,462	$4.45M	0.3%	-14.3%	0.017%
11/15/2023	Wahed Invest LLC	3,503	$0.41M	0.1%	+8.5%	0.002%
11/15/2023	AQR Capital Management LLC	109,883	$12.71M	0.0%	-1.1%	0.048%
11/14/2023	Troluce Capital Advisors LLC	25,002	$2.89M	1.1%	N/A	0.011%
11/14/2023	Bluefin Capital Management LLC	3,000	$0.35M	0.0%	-100.1%	0.001%
11/14/2023	AQR Arbitrage LLC	443,249	$51.28M	2.3%	+2.6%	0.194%
11/14/2023	Gotham Asset Management LLC	46,602	$5.39M	0.1%	+4.7%	0.020%
11/14/2023	Soros Fund Management LLC	3,289,584	$380.57M	5.4%	-0.1%	1.437%
11/14/2023	Alpine Global Management LLC	89,450	$10.35M	2.6%	-61.3%	0.039%
11/14/2023	California State Teachers Retirement System	347,380	$40.19M	0.1%	-4.2%	0.152%
11/14/2023	Toronto Dominion Bank	360,236	$41.68M	0.1%	-49.1%	0.157%
11/14/2023	Bank of Nova Scotia	297,009	$34.36M	0.1%	-44.2%	0.130%
11/14/2023	Qube Research & Technologies Ltd	727,409	$84.15M	0.2%	+27.7%	0.318%
11/14/2023	Samalin Investment Counsel LLC	8,680	$1M	0.6%	-1.9%	0.004%
11/14/2023	Treasurer of the State of North Carolina	105,384	$12.19M	0.1%	+0.5%	0.046%
11/14/2023	Meteora Capital LLC	11,000	$1.27M	0.2%	N/A	0.005%
11/14/2023	O Shaughnessy Asset Management LLC	2,635	$0.31M	0.0%	N/A	0.001%
11/14/2023	Profund Advisors LLC	12,664	$1.47M	0.1%	-14.8%	0.006%
11/13/2023	Connor Clark & Lunn Investment Management Ltd.	23,498	$2.72M	0.0%	+3.6%	0.010%
11/13/2023	Meiji Yasuda Asset Management Co Ltd.	14,346	$1.66M	0.1%	+176.1%	0.006%
11/13/2023	Northern Trust Corp	1,604,037	$185.57M	0.0%	+6.7%	0.700%
11/13/2023	Stifel Financial Corp	46,122	$5.34M	0.0%	-35.5%	0.020%
11/13/2023	Renaissance Group LLC	3,917	$0.45M	0.0%	-23.8%	0.002%
11/13/2023	Healthcare of Ontario Pension Plan Trust Fund	264,287	$30.58M	0.1%	+10.1%	0.115%
11/13/2023	Mariner LLC	15,781	$1.83M	0.0%	-76.1%	0.007%
11/13/2023	Ontario Teachers Pension Plan Board	10,197	$1.18M	0.0%	+66.5%	0.004%
11/13/2023	Clearbridge Investments LLC	105,901	$12.25M	0.0%	-53.7%	0.046%
11/13/2023	Hsbc Holdings PLC	751,453	$86.96M	0.1%	+12.2%	0.328%
11/13/2023	CI Investments Inc.	4,423	$0.51M	0.0%	-12.3%	0.002%
11/13/2023	Invesco Ltd.	361,398	$41.81M	0.0%	+15.7%	0.158%
11/13/2023	Balentine LLC	1,758	$0.20M	0.0%	N/A	0.001%
11/13/2023	Wolverine Asset Management LLC	39,899	$4.62M	0.1%	+22.4%	0.017%
11/13/2023	FMR LLC	205,419	$23.77M	0.0%	+5.6%	0.090%
11/13/2023	Grantham Mayo Van Otterloo & Co. LLC	123,376	$14.27M	0.1%	-60.6%	0.054%
11/13/2023	GWM Asset Management Ltd	323,528	$37.30M	32.0%	+223.5%	0.141%
11/13/2023	Korea Investment CORP	96,813	$11.20M	0.0%	-56.0%	0.042%
11/13/2023	Rafferty Asset Management LLC	77,078	$8.92M	0.1%	-8.0%	0.034%
11/13/2023	Prudential PLC	7,742	$0.90M	0.0%	-16.3%	0.003%
11/13/2023	Aviva PLC	32,349	$3.74M	0.0%	+36.5%	0.014%
11/13/2023	DekaBank Deutsche Girozentrale	101,655	$11.65M	0.0%	-32.6%	0.044%
11/13/2023	PNC Financial Services Group Inc.	4,429	$0.51M	0.0%	-90.1%	0.002%
11/13/2023	E Fund Management Co. Ltd.	3,962	$0.46M	0.0%	-12.0%	0.002%
11/9/2023	Rhumbline Advisers	306,817	$35.50M	0.0%	-1.4%	0.134%
11/9/2023	Deutsche Bank AG	728,802	$84.32M	0.0%	-68.0%	0.318%
11/9/2023	Andra AP fonden	78,100	$9.04M	0.5%	-41.4%	0.034%
11/9/2023	Mitsubishi UFJ Trust & Banking Corp	155,428	$17.98M	0.0%	-1.2%	0.068%
11/9/2023	Canada Pension Plan Investment Board	143,547	$16.61M	0.0%	-67.0%	0.063%
11/8/2023	State of New Jersey Common Pension Fund D	122,786	$14.21M	0.1%	-2.6%	0.054%
11/8/2023	State Board of Administration of Florida Retirement System	258,205	$29.87M	0.1%	-0.3%	0.113%
11/8/2023	HighTower Advisors LLC	2,815	$0.33M	0.0%	-4.3%	0.001%
11/8/2023	Pathstone Family Office LLC	2,355	$0.27M	0.0%	N/A	0.001%
11/8/2023	Vanguard Personalized Indexing Management LLC	22,313	$2.58M	0.1%	+2.8%	0.010%
11/8/2023	Charles Schwab Investment Management Inc.	935,067	$108.18M	0.0%	-1.0%	0.408%
11/8/2023	Sequoia Financial Advisors LLC	2,656	$0.31M	0.0%	+11.3%	0.001%
11/8/2023	Gabelli Funds LLC	414,455	$47.95M	0.4%	+5.5%	0.181%
11/8/2023	GABELLI & Co INVESTMENT ADVISERS INC.	351,075	$40.62M	6.6%	+6.9%	0.153%
11/8/2023	Gamco Investors INC. ET AL	49,265	$5.70M	0.1%	+44.7%	0.022%
11/8/2023	Janney Montgomery Scott LLC	1,816	$0.21M	0.0%	-46.6%	0.001%
11/8/2023	Alpine Associates Management Inc.	1,011,600	$117.03M	6.1%	-1.3%	0.442%
11/8/2023	New Jersey Better Educational Savings Trust	1,900	$0.22M	0.5%	N/A	0.001%
11/8/2023	Swiss National Bank	699,656	$80.94M	0.1%	-10.7%	0.306%
11/8/2023	PGGM Investments	9,989	$1.16M	0.0%	N/A	0.004%
11/8/2023	Amalgamated Bank	25,658	$2.97M	0.0%	+7.0%	0.011%
11/8/2023	J.P. Morgan Private Wealth Advisors LLC	2,277	$0.26M	0.0%	+4.2%	0.001%
11/8/2023	Moody Aldrich Partners LLC	2,417	$0.28M	0.1%	N/A	0.001%
11/8/2023	New York Life Investment Management LLC	268,034	$31.01M	0.3%	+3.6%	0.117%
11/7/2023	Summit Financial LLC	15,842	$1.83M	0.1%	-8.7%	0.007%
11/7/2023	Virtus ETF Advisers LLC	7,381	$0.85M	0.5%	+6.6%	0.003%
11/7/2023	New York State Common Retirement Fund	186,470	$21.57M	0.0%	-37.1%	0.081%
11/7/2023	Metis Global Partners LLC	5,556	$0.64M	0.0%	+12.3%	0.002%
11/7/2023	Barclays PLC	699,553	$80.93M	0.1%	-28.6%	0.305%
11/7/2023	Jump Financial LLC	2,820	$0.33M	0.0%	-31.5%	0.001%
11/7/2023	Arizona State Retirement System	59,332	$6.86M	0.1%	+0.2%	0.026%
11/7/2023	abrdn plc	40,812	$4.72M	0.0%	-29.3%	0.018%
11/7/2023	Mitsubishi UFJ Kokusai Asset Management Co. Ltd.	90,598	$10.48M	0.0%	+7.0%	0.040%
11/7/2023	Trium Capital LLP	128,426	$14.86M	0.2%	N/A	0.056%
11/6/2023	Privium Fund Management UK Ltd	63,147	$7.31M	5.7%	+181.3%	0.028%
11/6/2023	Illinois Municipal Retirement Fund	10,895	$1.26M	0.0%	-91.2%	0.005%
11/6/2023	RPO LLC	3,500	$0.41M	0.5%	N/A	0.002%

Data available starting January 2016

Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. Its portfolio comprises 12 medicines in the areas of rare diseases, gout, ophthalmology, and inflammation. It markets TEPEZZA (teprotumumab-trbw) for intravenous infusion; KRYSTEXXA (pegloticase injection) for intravenous infusion; RAVICTI (glycerol phenylbutyrate) oral liquid; PROCYSBI (cysteamine bitartrate) delayed-release capsules and granules for oral use; ACTIMMUNE (interferon gamma-1b) injection for subcutaneous use; BUPHENYL (sodium phenylbutyrate) tablets and powder for oral use; QUINSAIR (levofloxacin) solution for inhalation; and UPLIZNA (inebilizumab-cdon) injection for intravenous use. The company also markets PENNSAID (diclofenac sodium topical solution) for topical use; DUEXIS (ibuprofen/famotidine) tablets for oral use; RAYOS (prednisone) delayed-release tablets for oral use; and VIMOVO (naproxen/esomeprazole magnesium) delayed-release tablets for oral use. It has collaboration agreements with HemoShear Therapeutics, LLC; Alpine Immune Sciences, Inc.; Halozyme Therapeutics, Inc.; Arrowhead Pharmaceuticals, Inc.; Q32 Bio Inc.; and Xeris Biopharma Holdings, Inc. The company was formerly known as Horizon Pharma Public Limited Company and changed its name to Horizon Therapeutics Public Limited Company in May 2019. Horizon Therapeutics Public Limited Company was founded in 2005 and is headquartered in Dublin, Ireland.

Today's Range

Now: $116.30

$116.30

50 Day Range

MA: $115.72

$112.60

$116.30

52 Week Range

Now: $116.30

$60.03

$116.38

Volume

N/A

Average Volume

2,498,525 shs

Market Capitalization

$26.63 billion

P/E Ratio

62.19

Dividend Yield

N/A

Beta

1.03

Who are the company insiders with the largest holdings of Horizon Therapeutics Public?: Horizon Therapeutics Public's top insider shareholders include:
Andy Pasternak (EVP)
Jeffrey W Sherman (EVP)
Aaron Cox (CFO)
Learn More about top insider investors at Horizon Therapeutics Public.